IMRA saw its Momentum Indicator move below the 0 level on June 17, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator turned negative. In of the 51 cases, the stock moved further down in the following days. The odds of a decline are at .
IMRA moved below its 50-day moving average on June 12, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IMRA crossed bearishly below the 50-day moving average on June 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for IMRA entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 43 cases where IMRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
IMRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
a company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies
Category Unknown